CASI PHARMACEUTICALS (CASIF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 76 143 sessions, February 26, 2026 to October 19, 2026
- Largest daily move
- +42.9% close of June 12, 2026
- 1-month change
- -22.3% closing prices, September 18, 2026 to October 19, 2026
Company Description
CASI PHARMACEUTICALS (OTC: CASIF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.1M.
CASIF has declined 22.3% over the past month. The last closing price was $0.1001.
For FY2025, CASI PHARMACEUTICALS reported revenue of $20.7M with net income of -$48.1M and diluted earnings per share of -$2.59. The company operates at a net profit margin of -232.0%.
This page collects what Stock Titan holds for CASIF, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
CASI PHARMACEUTICALS (CASIF) closed at $0.1001 on October 19, 2026. Over the past month, the price has lost 22.3%.
CASIF Metrics & Rankings
Price returns through October 19, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CASI PHARMACEUTICALS has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include earnings. View all CASIF news →
SEC Filings
CASI PHARMACEUTICALS has filed 10 recent SEC filings, including 6 Form 6-K, 1 Form 3, 1 Form 25-NSE, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CASIF SEC filings →
Financial Highlights
CASI PHARMACEUTICALS generated $20.7M in revenue in FY2025, retaining a 48.6% gross margin, operating income reached -$45.0M (-217.3% operating margin), and net income was -$48.1M, reflecting a -232.0% net profit margin. Diluted earnings per share stood at -$2.59. The company generated -$20.8M in operating cash flow. The current ratio was 0.27, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in CASI PHARMACEUTICALS (CASIF) currently stands at 144.4 thousand shares, down 0.1% from the previous reporting period, representing 1.4% of the float. Since February 2026, short interest has decreased by 68.0%.
Days to Cover History
Days to cover for CASI PHARMACEUTICALS (CASIF) currently stands at 95.7 days, up 258.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 9465%. Across the settlements charted above, it has ranged from 1.0 to 95.7 days.
CASIF Company Profile & Sector Positioning
CASI PHARMACEUTICALS (CASIF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.